Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Effect of Osmolar Stress on Human Meibomian Gland Epithelial Cells–an in vitro Study.
Author Affiliations & Notes
  • Amanda Prislovsky
    VA Medical Center, Memphis, Tennessee, United States
    Ophthalmology, University of Tennessee, Memphis, Tennessee, United States
  • Ashlyn Gary
    University of Miami Mary and Edward Norton Library of Ophthalmology, Miami, Florida, United States
  • Anat Galor
    University of Miami Mary and Edward Norton Library of Ophthalmology, Miami, Florida, United States
    VA Medical Center, Memphis, Tennessee, United States
  • Nawajes Mandal
    VA Medical Center, Memphis, Tennessee, United States
    Ophthalmology, University of Tennessee, Memphis, Tennessee, United States
  • Footnotes
    Commercial Relationships   Amanda Prislovsky None; Ashlyn Gary None; Anat Galor None; Nawajes Mandal None
  • Footnotes
    Support  Biomedical Laboratory R&D (BLRD) Service I01 BX004893
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 5729. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Amanda Prislovsky, Ashlyn Gary, Anat Galor, Nawajes Mandal; Effect of Osmolar Stress on Human Meibomian Gland Epithelial Cells–an in vitro Study.. Invest. Ophthalmol. Vis. Sci. 2024;65(7):5729.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Dry eye disease (DED) is a spectrum of ocular surface disease that affects 5-30% of people over 50 and an estimated 300M people in the world suffer from DED. Meibomian glands (MG), which are modified holocrine glands, secrete meibomian lipids or meibum for the tear film. DED is often driven by meibomian gland dysfunction (MGD). The Mechanism of MGD is not well understood. The purpose of this study was to investigate the health and functionality of meibomian gland cells in an in vitro model of osmolar stress.

Methods : We developed an in vitro model of cultured Human Meibomian Gland Epithelial Cells (HMGEC) and subjected them to osmolar stress to simulate DED. Immortal HMGEC were gifted by Dr. David Sullivan (Schepens Eye Research Institute) and grown in two different conditions) keratinocyte serum-free media (KSFM) with 5ng/ml epidermal growth factor and 50ug/ml bovine pituitary extract to maintain their undifferentiated states and 2) with DMEM with 10% FBS that allows them to differentiate. HMGECs were grown to 70–80% confluence and subjected to osmolar stress with an increased dose of NaCl from 50–150mM for 24h. The dose-response of NaCl on cell viability and survival was determined by MTT and LDH assays. Expression of inflammatory, cell adhesion, and sphingolipid pathways genes were determined by qRT-PCR. The release of inflammatory mediators was assayed using a multiplex assay.

Results : 50–150mM NaCl increased the osmolarity of the media from 396 to 777mOsm/kg, the osmolarity of no salt was 297mOsm/kg. In KSFM, NaCl reduced cell viability by 7% (50), 43% (100), & 60% (150mM NaCl). Cell death was induced by 15% (100) & 29% (150mM NaCl). For differentiated cells, NaCl reduced cell viability by 2% (50), 12% (100), & 62% (150mM NaCl) and induced 59% cell death in150 mM NaCl. Only differentiated cells showed elevated expression of inflammatory genes (IL-1b and IL-18) under osmolar stress. On the other hand, undifferentiated cells released increased levels of IL-1b, MMP-3, TNF alpha, & CXCL11, while the levels of secreted MMP-2, MMP-9 & TIMP-1 reduced.

Conclusions : This study underscores the adverse effects of increased osmolarity on meibomian gland cells and revealed distinct responses between states of the cells. The findings emphasize the vulnerability of these cells to osmotic stress, indicating potential pathways and mechanisms involved in dry eye pathogenesis.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×